GlaxoSmithKline: all 4,196 studies
Page 29 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy VolunteersCompletedNCT01449799Phase 1
- To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult SubjectsCompletedNCT01449188Phase 1
- Cardiovascular and Torsades de Pointes Monitoring for PazopanibCompletedNCT01446224
- ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)CompletedNCT01445600
- A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple MyelomaWithdrawnNCT01445587Phase 2
- Drug Use Investigation for XYZAL®CompletedNCT01445262
- Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related SurgeryCompletedNCT01444612
- A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.WithdrawnNCT01440361Phase 2
- Topiramate Bioequivalence Study Brazil - FastCompletedNCT01439438Phase 1
- Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and RomiplostimCompletedNCT01439321
- Intranasal SB-705498 in Non-allergic Rhinitis PatientsCompletedNCT01439308Phase 2
- Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple SclerosisTerminatedNCT01435993Phase 1
- Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™CompletedNCT01435967
- Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination TherapyCompletedNCT01435954
- Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic MigraineCompletedNCT01435941
- Ropinirole PR Pharmacokinetics Study Among Chinese Healthy SubjectsCompletedNCT01435915Phase 1
- A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With ExerciseWithdrawnNCT01435902Phase 3
- Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative ColitisWithdrawnNCT01434576Phase 1
- Assessment of Repeat Ascending Doses of GSK2018682 in Healthy VolunteersCompletedNCT01431937Phase 1
- Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma PatientsCompletedNCT01431924
- Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease ExacerbationCompletedNCT01431911
- Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)CompletedNCT01428544
- Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism TreatmentCompletedNCT01428531
- Special Drug Use Investigation for LAMICTAL BipolarCompletedNCT01428518
- [18F]PBR111 and Microglial Activation in Multiple SclerosisTerminatedNCT01428505Phase 2
- Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese MalesCompletedNCT01428479Phase 1
- Japanese Phase 1 Study of GSK2585823CompletedNCT01428466Phase 1
- PET Study to Study Tumour ApoptosisTerminatedNCT01428440Phase 2
- Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid TumorsCompletedNCT01428427Phase 1
- Drug Interaction Study Between Dolutegravir and PrednisoneCompletedNCT01425099Phase 1
- Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805CompletedNCT01424540Phase 1
- Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation StudyCompletedNCT01424527
- LRRK2 Mutation and Parkinson's DiseaseTerminatedNCT01424475Phase 1
- Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.CompletedNCT01424462Phase 1
- A PET Study in Healthy VolunteersCompletedNCT01424449Phase 1
- Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease PatientCompletedNCT01424436Phase 1
- NOGO-A in Multiple Sclerosis FTIHTerminatedNCT01424423Phase 1
- Emotional Processing in Healthy Volunteers in the Presence of an Investigational AnxiolyticCompletedNCT01424384Phase 1
- Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia MyelofibrosisCompletedNCT01423058Phase 1/2
- Special Drug Use Investigation for ALLERMIST (Long Term)CompletedNCT01420822
- Special Drug Use Investigation for ARIXTRA® (Fondaparinux) InjectionCompletedNCT01420809
- A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched StrainsCompletedNCT01416597
- Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced InflammationCompletedNCT01416376Phase 1
- Healthy Volunteer Study Using 3 Different Formulations of FirategrastCompletedNCT01416363Phase 1
- A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With AzithromycinCompletedNCT01416350Phase 1
- Absolute Bioavialability of GSK1120212CompletedNCT01416337Phase 1
- First Time in Human Study Using GSK2330672CompletedNCT01416324Phase 1
- A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of RosuvastatinCompletedNCT01411111Phase 1
- Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal ImpairmentTerminatedNCT01406340Phase 1
- Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)CompletedNCT01406327
- SAP Depleter Dose Assessment Study in PatientsCompletedNCT01406314Phase 1
- Fondaparinux EU-RMP (Adherence)CompletedNCT01406301
- Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)CompletedNCT01406275
- Albiglutide Thorough ECG Study in Healthy VolunteersCompletedNCT01406262Phase 1
- Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating TreatmentCompletedNCT01395875
- Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)CompletedNCT01395862
- Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)CompletedNCT01395849
- A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell HistiocytosisCompletedNCT01395004Phase 2
- SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real WorldCompletedNCT01390935
- Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)CompletedNCT01390922
- Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General SurgeryCompletedNCT01390896
- Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)CompletedNCT01390883
- Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)CompletedNCT01390805
- Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)CompletedNCT01390792
- Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)CompletedNCT01390766
- Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy AdultsCompletedNCT01389479Phase 3
- Survey on the Pharmacy Follow-up of Alli PurchasersCompletedNCT01387243
- GSK2018682 FTIH in Healthy VolunteersCompletedNCT01387217Phase 1
- Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212CompletedNCT01387204Phase 1
- Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mgCompletedNCT01387191
- Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in LatinaCompletedNCT01387165
- Relative Bioavailability Study of a Pediatric Granule Formulation of DolutegravirCompletedNCT01382238Phase 1
- A Study to Compare Two Paracetamol TabletsWithdrawnNCT01381640Phase 1
- Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)CompletedNCT01381614
- Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)CompletedNCT01381601
- The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal WomenCompletedNCT01381588
- Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01381536Phase 1
- A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World DataCompletedNCT01381523
- Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan DatabaseCompletedNCT01381510
- Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan MonotherapyCompletedNCT01381497
- Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post ExacerbationCompletedNCT01381458
- A Study Assessing GW870086's Potential to Cause Skin ThinningCompletedNCT01381445Phase 1
- Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)CompletedNCT01381432
- First Time in Human Study (FTIH) With Positron Emission Tomography (PET)CompletedNCT01381419Phase 1
- BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )CompletedNCT01381393
- Drug Use Investigation for AVOLVE(BPH)CompletedNCT01376284
- Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)CompletedNCT01376271
- Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan DatabaseCompletedNCT01376258
- Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)CompletedNCT01376232Phase 1
- European Cost of Asthma TreatmentCompletedNCT01376219
- Drug Use Investigation for ALLERMISTCompletedNCT01376206
- Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) TabletCompletedNCT01376193
- Drug Use Investigation for LAMICTALCompletedNCT01376180
- Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)CompletedNCT01376154
- Drug Use Investigation for IMIGRAN TabletCompletedNCT01376141
- Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)CompletedNCT01376128
- BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)CompletedNCT01376102
- GSK2239633 FTIH StudyCompletedNCT01371812Phase 1
- A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy SmokersCompletedNCT01371799Phase 1
- A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and ArandaCompletedNCT01371682Phase 1